- Countries/Regions
- United States of AmericaCzech RepublicGermanyItalySwitzerland
- Category
- Research
- Academic Field
- Medicine
- Related goals of SDGs
Keyword |
renal cell carcinoma, renal tumor, pathology, urology, genome, transcriptome, WHO classification |
Information on Niigata University
Name of the professor/researcher |
Riuko Ohashi |
Position/Faculty |
Professor; Institute of Medicine and Dentistry |
Information on the Counterpart
Countries/Regions |
Switzerland, Germany, Italy, Czech Republic, USA |
Faculty/Institution |
(1)University and University Hospital Zurich (2)University Hospital Erlangen, Friedrich-Alexander-University Erlangen-N?rnberg (3)University of Verona (4)Technical University Munich (5)Charles University in Prague, University Hospital in Plzen (6)Houston Methodist Hospital |
Detailed Information/Report on Activities
We investigate the clinicopathological and molecular characteristics of renal tumors and construct a comprehensive renal tumor database. This database can be used for the following; researches for 1) proposal of a new histological subtype classification, 2) establishment of diagnostic criteria, 3) development of a new pathological diagnostic method, 4) proposal of a grading system, 5) elucidation of the mechanism of development and progression of renal tumors, 6) development of new treatment and drugs, as well as 7) education for young doctors and 8) continuous education for professionals. Through these efforts, we aim to improve the quality of renal cancer treatment and medical care in Niigata, Japan, and the world.
This is an international multi-institutional collaboration study with more than 40 institutions, including the authors of the WHO classification.